跳至主要内容
临床试验/ISRCTN42613663
ISRCTN42613663已完成2 期

Establishing the efficacy of advanced semi-automated functional magnetic resonance (MR) imaging in the early prediction of response of locally advanced breast cancer to neoadjuvant chemotherapy: a pilot study

Hull and East Yorkshire NHS Trust (UK)0 个研究点目标入组 52 人开始时间: 2009年6月17日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. Provide written informed consent
  • 3. Aged 18 years or over
  • 4. Newly diagnosed, histologically proven breast cancer (TNM stage T2- T4B, N0-3C, and M0)
  • 5. Undergone both x-ray mammography and breast ultrasound scanning during the current treatment episode
  • 6. Scheduled for neo-adjuvant chemotherapy

排除标准

  • 1. Are medically unstable
  • 2. Previously undergone chemotherapy
  • 3. Have had surgery or radiotherapy for cancer in the ipsilateral breast
  • 4. Have had surgery to the ipsilateral breast within the previous 4 months for benign breast disease
  • 5. Have a history of serious breast trauma within the last 3 months
  • 6. Are pregnant or breast feeding
  • 7. Have renal failure
  • 8. Fail the normal safety requirements of MR, particularly pacemakers and cardiac defibrillators
  • 9. Are known to have had an allergic reaction associated with previous administration of a paramagnetic contrast agent
  • 10. Have a known contraindication to MR scanning
  • 11. Have a disability preventing MR scanning in the prone position
  • 12. Have body habitus incompatible with MR system entry

研究者

发起方
Hull and East Yorkshire NHS Trust (UK)

相似试验